Who Paid My Doc
Fazela Wasimi
Clinical Nurse Specialist, Family Health San Diego, CA Nurse Practitioner
NPI 1780024588 CMS profile 11185549
4692 Mission Blvd, San Diego, CA 92109
General payments
$228
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Fazela Wasimi of San Diego, CA is reported in the CMS Open Payments database as having received $228 across 8 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 42nd percentile of Clinical Nurse Specialist, Family Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $228 | 8 |
Beside peers
- Fazela Wasimi
- Clinical Nurse Specialist, Family Health median
- Middle half of Clinical Nurse Specialist, Family Health
- National median
In program year 2025, general payments to Fazela Wasimi were reported at $0. Among 164 Clinical Nurse Specialist, Family Health profiles paid that year, the median was $216 and the middle half received between $57 and $492.
Show as a table
| Year | Fazela Wasimi | Clinical Nurse Specialist, Family Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $151 | $46–$400 | $132 |
| 2022 | $228 | $153 | $37–$527 | $149 |
| 2023 | $0 | $139 | $50–$451 | $160 |
| 2024 | $0 | $150 | $46–$571 | $164 |
| 2025 | $0 | $216 | $57–$492 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 80 drugsPart D claims
3,914
Drug cost
$469,781
Branded share of claims
17.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 78 | $79,199 | |
| Trulicity Dulaglutide | Brand | 49 | $50,206 | |
| Linzess Linaclotide | Brand | 81 | $43,166 | |
| Eliquis Apixaban | Brand | 60 | $36,479 | |
| Jardiance Empagliflozin | Brand | 54 | $33,358 | |
| Atorvastatin Calcium | Generic | 410 | $22,265 | |
| Januvia Sitagliptin Phosphate | Brand | 29 | $16,538 | |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 23 | $15,913 | |
| Spiriva Respimat Tiotropium Bromide | Brand | 22 | $12,265 | |
| Xarelto Rivaroxaban | Brand | 21 | $12,062 |
The 10 drugs with the highest cost, of 80 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,644 Part D prescribers listed as Certified Clinical Nurse Specialist; they describe a distribution and say nothing about conduct.
Records
8 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Family Health in California
Ami Flores
Clinical Nurse Specialist, Family Health · Chula Vista, CA
Marylyn Hagerty
Clinical Nurse Specialist, Family Health · San Clemente, CA
Carrie Clark
Clinical Nurse Specialist, Family Health · Los Gatos, CA
Karen Greenhaw
Clinical Nurse Specialist, Family Health · Penn Valley, CA
Jody Reifenberger
Clinical Nurse Specialist, Family Health · Ramona, CA
Christianna Espinoza
Clinical Nurse Specialist, Family Health · San Diego, CA
Related records
Clinical Nurse Specialist, Family Health in California
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Family Health
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.